CTKB
Cytek Biosciences, Inc. · Healthcare · Medical - Devices
Momentum-inputs (vergelijkbare managers): breedte van houders 0.0% · aandelenstroom -10.1% · netto nieuwe posities 0.0% — formule
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q1 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 74 | 0 | 60.52M | $268.04M | +6 | −6 |
| Q1 2026 | 76 | +1 | 60.92M | $266.22M | +4 | −3 |
| Q4 2025 | 75 | -1 | 61.04M | $308.28M | — | −1 |
| Q3 2025 | 19 | +4 | 43.35M | $150.42M | +4 | — |
| Q2 2025 | 12 | 0 | 36.22M | $123.14M | +1 | −1 |
| Q1 2025 | 9 | 0 | 9.63M | $38.61M | +1 | −1 |
| Q4 2024 | 9 | +1 | 10.70M | $69.47M | +1 | — |
| Q3 2024 | 7 | 0 | 5.47M | $30.29M | — | — |
| Q2 2024 | 7 | — | 6.05M | $33.76M | — | — |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (passief) | 4.38M | -2.8% | $17.57M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passief) | 2.69M | +1.8% | $10.78M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 3 | Geode Capital Management ✦ (passief) | 2.69M | +1.8% | $10.78M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 4 | Renaissance Technologies ✦ | 687.60K | +48.6% | $2.76M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 5 | AQR Capital Management ✦ | 653.28K | +394.4% | $2.62M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 6 | AQR Capital Management ✦ | 653.28K | +394.4% | $2.62M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 7 | AQR Capital Management ✦ | 653.28K | +394.4% | $2.62M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 8 | AQR Capital Management ✦ | 653.28K | +394.4% | $2.62M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 9 | AQR Capital Management ✦ | 653.28K | +394.4% | $2.62M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 10 | Citadel Advisors ✦ | 602.52K | +199.6% | $2.42M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 11 | Citadel Advisors ✦ | 602.52K | +199.6% | $2.42M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 12 | Millennium Management ✦ | 495.44K | -38.4% | $1.99M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 13 | T. Rowe Price ✦ | 53.34K | +13.0% | $214,000 | 0.0% | ▲ Add | 4 | SEC ↗ |
| 14 | Arrowstreet Capital ✦ | 48.15K | Nieuw | $193,098 | 0.0% | New | 1 | SEC ↗ |
| 15 | Point72 Asset Management ✦ | 17.50K | -95.5% | $70,159 | 0.0% | ▼ Trim | 2 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Arrowstreet Capital | $193,098 | 0.0% |
Verlaten
| Wellington Management | $9.85M | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 164 houders, 84.77M aandelen, $364.62M gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.